Script count and prescription mix
Daily and monthly script volume, refill percentage, brand versus generic mix, and trend over three years are the core of the valuation.
El Paso Owner's Guide · Independent & Compounding Pharmacies
A pharmacy's value is written in its script log. Buyers price daily script count, reimbursement quality, front-end and specialty margin, and whether the prescriber relationships belong to the store or to the pharmacist behind the counter.
The Local Market
El Paso's population, its medical corridor, and strong neighborhood loyalty support independents that larger chains cannot easily replicate. Buyers include pharmacists buying their first store, small local groups, and chains buying script files.
Daily and monthly script volume, refill percentage, brand versus generic mix, and trend over three years are the core of the valuation.
Gross margin per script, third-party contracts, DIR and fee pressure, and the balance of cash versus insurance business determine how durable the profit is.
Retail front-end margin, compounding, immunizations, durable medical equipment, delivery, and long-term-care servicing all diversify revenue and lift the multiple.
Referral concentration from one or two prescribers is a risk. Retained pharmacists and technicians are what let volume survive the transition.
Free Estimator · No Email Required
Move the slider. This uses owner's discretionary earnings (SDE) — your net profit plus your salary, personal expenses run through the business, interest, depreciation, and one-time costs. Saleable inventory is typically valued in addition.
$180,000 / year
Which of these are true today?
Illustrative Range
Estimated enterprise value
$405,000 – $711,000
That’s roughly 2.3× to 4.0× your owner’s earnings, before any real estate you own.
Every box you check is a lever you can still pull before you list. Owners who fix the books and the lease first routinely land at the top of their range instead of the bottom.
Illustration only — not an appraisal or an offer.
Step by Step
Three years of P&Ls and tax returns, reconciled, plus monthly script counts, gross margin per script, payer mix, front-end sales, inventory at cost, and any specialty service revenue.
Not a broker's opinion, and never a chain's script-file offer. We commission a certified valuation from an independent NACVA-credentialed appraiser — the caliber of report banks, buyers, the IRS, and courts rely on.
Broader referral sources and added service lines reduce the risk a buyer is underwriting, and that reduction shows up directly in your price.
Licensing and DEA registration, controlled-substance recordkeeping and inventories, PSAO and third-party contracts, accreditation where applicable, software and records handling, wholesaler terms and rebates, lease term, and unpaid taxes.
No word to your staff, your patients, or the chain across the street. We market blind to vetted pharmacists, local groups, and qualified acquirers under NDA, so you compare offers instead of accepting one.
Offers, escrow, licensing and DEA transition for the buyer, contract consents, inventory count at closing, staff retention, and funding. We stay on it through closing.
Costly Mistakes
Chains buy files, not businesses, and they price for their own economics. A pharmacy with real earnings, front-end margin, and services is frequently worth substantially more sold as a going concern.
Referral concentration is the most heavily discounted risk in the category, because it can disappear the week after closing.
A buyer models margin per script going forward, not backward. Documented cash-pay and service revenue is the best defense against fee pressure.
Logs and inventories are examined closely by buyers, lenders, and regulators. Gaps delay closings and shrink your buyer pool.
Buyers pay cost for current, saleable stock at a closing count. Expired and slow-moving product is not value — convert it before listing.
Both talk, and script volume follows sentiment. Confidentiality protects the file the buyer is paying for.
Questions Owners Ask
Straight answers, no hedging. If yours isn’t here, call us and ask it directly.
Profitable independents commonly trade between roughly 2 and 4 times owner's discretionary earnings, with saleable inventory valued in addition. Script growth, margin per script, service diversification, and prescriber breadth determine where you land. Only a certified independent valuation survives a lender's underwriting.
It is one option, and sometimes the right one — but it is rarely the highest one for a profitable store with front-end and service revenue. You should know what the business is worth as a going concern before you accept a file price.
Typically it is handled separately and counted at closing, valued at cost for current, saleable product. Expired and unsaleable stock is generally excluded.
They do not transfer. The buyer must obtain pharmacy licensure and DEA registration in their own right, and that timeline belongs in the closing schedule from the beginning. Confirm requirements with your own counsel.
Qualified buyers can access SBA 7(a) financing up to $5 million, and independent pharmacies are a familiar lender profile. It requires clean, reconciled financials and a defensible independent valuation. SBA pre-qualification is a preliminary, non-binding lender assessment, not a loan commitment.
Not from us. Your store is marketed blind to vetted buyers who sign a non-disclosure agreement before they learn the location or the name.
Where we work
Whether your independent pharmacy sits on the east side, downtown, out in the valley, or across the state line in Doña Ana County, the sale process is the same: verified financials, an independent certified valuation, and a confidential, competitive market of qualified buyers. We meet owners at a time and place of their choosing.
Independent Pharmacy Owners · Confidential
One confidential conversation with a partner — not a coordinator. We will tell you where your numbers put you today, what would move the multiple, and whether now is your moment.